<DOC>
	<DOCNO>NCT00648323</DOCNO>
	<brief_summary>The primary objective determine efficacy safety GITS formulation Doxazosin Taiwanese patient prostate enlargement .</brief_summary>
	<brief_title>Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System ( GITS ) In Patients With Prostate Enlargement</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Taiwanese male subject 50 80 year age : primary diagnosis BPH , define enlarge prostate ( confirmed digital rectal examination [ DRE ] and/or Bmode ultrasound ) ; IPSS score ≥12 ; Qmax range 5 15 mL/sec total void volume ≥150 mL , eligible study . Exclusion criterion include limit : Previous prostate surgery , presence prostate stent microwave thermotherapy and/or balloon dilatation within previous 6 month Concomitant therapy previous therapy within 14 day agent know affect bladder urethral function .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Benign Prostate Hyperplasia</keyword>
</DOC>